Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
about
TARDBP mutation analysis in TDP-43 proteinopathies and deciphering the toxicity of mutant TDP-43Accumulation of transactive response DNA binding protein 43 in mild cognitive impairment and Alzheimer diseaseRapamycin rescues TDP-43 mislocalization and the associated low molecular mass neurofilament instabilityMolecular Pathological Classification of Neurodegenerative Diseases: Turning towards Precision MedicineTDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPTTherapeutic and diagnostic challenges for frontotemporal dementiaDoes a loss of TDP-43 function cause neurodegeneration?Neuropsychiatric Disturbances in Alzheimer's Disease: What Have We Learned from Neuropathological Studies?The tau tubulin kinases TTBK1/2 promote accumulation of pathological TDP-43Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants.Astrocytic TDP-43 pathology in Alexander diseasePlasma phosphorylated-TDP-43 protein levels correlate with brain pathology in frontotemporal lobar degeneration.A Drosophila model for TDP-43 proteinopathy.TDP-43 suppresses tau expression via promoting its mRNA instability.TDP-43 regulates its mRNA levels through a negative feedback loop.Transactive response DNA-binding protein 43 burden in familial Alzheimer disease and Down syndromeThe role of transactive response DNA-binding protein-43 in amyotrophic lateral sclerosis and frontotemporal dementia.TAR DNA-binding protein 43 in neurodegenerative disease.Phosphorylated TDP-43 pathology and hippocampal sclerosis in progressive supranuclear palsyTDP-43 pathology in primary progressive aphasia and frontotemporal dementia with pathologic Alzheimer disease.The influence of pathological mutations and proline substitutions in TDP-43 glycine-rich peptides on its amyloid properties and cellular toxicity.Frontotemporal lobar degeneration: epidemiology, pathophysiology, diagnosis and management.Granulovacuolar degenerations appear in relation to hippocampal phosphorylated tau accumulation in various neurodegenerative disorders.Poly-A binding protein-1 localization to a subset of TDP-43 inclusions in amyotrophic lateral sclerosis occurs more frequently in patients harboring an expansion in C9orf72TAR DNA-binding protein 43 pathology in Alzheimer's disease with psychosis.Probing the biology of Alzheimer's disease in mice.TDP-43 is a key player in the clinical features associated with Alzheimer's diseaseLack of shunt response in suspected idiopathic normal pressure hydrocephalus with Alzheimer disease pathology.Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosisIdentification of proteins sensitive to thermal stress in human neuroblastoma and glioma cell linesInteraction of transactive response DNA binding protein 43 with nuclear factor κB in mild cognitive impairment with episodic memory deficits.TDP-43 pathology occurs infrequently in multiple system atrophy.TDP-43 in aging and Alzheimer's disease - a reviewAn ALS-mutant TDP-43 neurotoxic peptide adopts an anti-parallel β-structure and induces TDP-43 redistribution.Pathological 43-kDa transactivation response DNA-binding protein in older adults with and without severe mental illness.Review: transactive response DNA-binding protein 43 (TDP-43): mechanisms of neurodegeneration.Motor neuron disease clinically limited to the lower motor neuron is a diffuse TDP-43 proteinopathy.Frontotemporal lobar degeneration: defining phenotypic diversity through personalized medicine.Rodent models of TDP-43 proteinopathy: investigating the mechanisms of TDP-43-mediated neurodegenerationOn the development of markers for pathological TDP-43 in amyotrophic lateral sclerosis with and without dementia.
P2860
Q24594172-6A0F5362-C009-478A-88DC-5CB4F207E8D3Q24634907-F017F9E1-5A37-4372-AE08-124A1A84B43CQ24648173-C486DD73-C612-4A70-8F99-522D9918B16AQ26768648-3EAB7F7B-E0C6-4695-8BB7-9D9C7EFB3DB4Q26851112-05D381B8-DD1C-43A4-9F7E-970DD6842AF3Q26998919-38FADFE8-6F88-4A2D-B0DF-C3C18A15A72CQ27026848-D0B7C99E-C21E-42C7-99FB-184FAFF87FF3Q28070156-356D4EC6-9A04-4BE9-AFC7-C94807B3BED6Q28542476-5F91107F-73DB-49E5-BC36-EB72136458B9Q33361835-2C5DB74A-A3A5-4B46-B972-366773C41A11Q33575134-C2A0C46E-2BD4-49DB-AE30-E5C5CA56BDDDQ33601762-FD1AC87B-C87E-44A0-9C69-F69223EB1923Q33733651-5EF772AD-6140-4464-81DF-25470652CF07Q33740999-D90AC92E-567A-47AB-A47A-0867584F926CQ33763346-7DC3B4E5-FD1B-4A5F-8B2B-93D5ADEE0C9CQ33830061-C966E568-D07B-4C90-AAE7-8504BD7E7446Q33847532-CBBB451A-FF25-4B1A-A6FC-A025E4EFC130Q33941040-42AB0A04-1A39-465E-8AC7-B4CF60512012Q33984304-CF6748F8-4CC3-4FEF-A17B-6A6B0122A545Q33992842-FBFCC6A5-7103-4330-8743-9C127473C0F2Q33999609-19DDBD65-AB1C-460A-9489-505F54448391Q34046590-8838F8F3-D2A9-4B98-A70E-2F57543ED53EQ34071708-A1A1AF34-9A4C-42C3-9F5D-9508115ECE15Q34109160-EDB38C2F-0306-4015-9DE8-7A81864C5CF5Q34147753-6F4EEE32-143E-4463-94AD-86FDC18CF3EFQ34206962-DC92E469-84CA-421F-B2CC-C970552FBB78Q34232167-F65066B2-70E4-49BF-A2BB-F460071DD74CQ34242658-AE2D79EF-6418-49F8-8547-8298EB1B249FQ34312322-1E5261DE-B7BC-4A52-B987-1119E5BB0042Q34473876-F9B85C45-D201-486F-B777-1A75B7262AA8Q34504310-368318BD-327D-4E30-B11E-B8D4E2ADEF30Q34538142-1F4962EE-0AC8-45B1-824B-6F5CAF6206DFQ34566756-C096CA8B-F75C-458D-AF58-62A9768AA672Q34575728-85B0E531-5420-4A21-9983-ED7B928420DEQ34632269-6BF03F55-9DA0-453C-AF42-A2E24AE3242AQ34642738-DEB83300-463C-423B-AD67-48FA039C81FAQ35075257-428F8FFA-8168-475F-9567-3F72B567FE05Q35204586-60CFE4D2-6228-4678-865C-7F93F559A0EAQ35512201-93ECB46B-7D4D-4B99-9644-F67453504501Q35592875-24634535-EBF3-42EC-8F3D-AACF96C83C1E
P2860
Concomitant TAR-DNA-binding protein 43 pathology is present in Alzheimer disease and corticobasal degeneration but not in other tauopathies.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
2008年论文
@zh
2008年论文
@zh-cn
name
Concomitant TAR-DNA-binding pr ...... but not in other tauopathies.
@en
type
label
Concomitant TAR-DNA-binding pr ...... but not in other tauopathies.
@en
prefLabel
Concomitant TAR-DNA-binding pr ...... but not in other tauopathies.
@en
P2093
P2860
P50
P1476
Concomitant TAR-DNA-binding pr ...... but not in other tauopathies.
@en
P2093
Christopher M Clark
Hanae Nakashima-Yasuda
Hans A Kretzschmar
Kunihiro Uryu
Linda K Kwong
Mark S Forman
Virginia M-Y Lee
P2860
P304
P356
10.1097/NEN.0B013E31817713B5
P577
2008-06-01T00:00:00Z